Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chipkin

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Pharmacology, Biochemistry, and Behavior|July 1, 1978
Brief communication. Generalization of [DAla2]-enkephalinamide but not of substance P to the morphine cueR E Chipkin, J M Stewart, D H Morris, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase AR E Chipkin, L C Iorio, A Barnett, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1979
In vitro activities of some synthetic substance P analogsR E Chipkin, J M Stewart, V E Sweeney, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primatesT L Yaksh, M B Sabbe, D Lucas, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
In vivo binding of SCH 39166: a D-1 selective antagonistR D McQuade, R A Duffy, V L Coffin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Inhibition of development of tolerance to morphine by a peptide related to ACTHJ M Stewart, R E Chipkin, K Channabasavaiah, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1985
Pharmacological effects of SCH 30497--a novel analgesic substanceR E Chipkin, M B Latranyi, L C Iorio, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesicR E Chipkin, J G Berger, W Billard, et al.
Life Sciences|January 1, 1988
Serotonergic component of SCH 23390: in vitro and in vivo binding analysesR D McQuade, D Ford, R A Duffy, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activityR E Chipkin, L C Iorio, V L Coffin, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|July 1, 1978
Brief communication. Generalization of [DAla2]-enkephalinamide but not of substance P to the morphine cueR E Chipkin, J M Stewart, D H Morris, et al.
Advances in Biochemical Psychopharmacology|January 1, 1982
In vitro and in vivo effects of thiorphan: an inhibitor of enkephalinase AR E Chipkin, L C Iorio, A Barnett, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1979
In vitro activities of some synthetic substance P analogsR E Chipkin, J M Stewart, V E Sweeney, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primatesT L Yaksh, M B Sabbe, D Lucas, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
In vivo binding of SCH 39166: a D-1 selective antagonistR D McQuade, R A Duffy, V L Coffin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Inhibition of development of tolerance to morphine by a peptide related to ACTHJ M Stewart, R E Chipkin, K Channabasavaiah, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1985
Pharmacological effects of SCH 30497--a novel analgesic substanceR E Chipkin, M B Latranyi, L C Iorio, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesicR E Chipkin, J G Berger, W Billard, et al.
Life Sciences|January 1, 1988
Serotonergic component of SCH 23390: in vitro and in vivo binding analysesR D McQuade, D Ford, R A Duffy, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activityR E Chipkin, L C Iorio, V L Coffin, et al.
Pageof 5